Latest Breaking News On - Insider activity at kiniksa pharmaceuticals - Page 1 : vimarsana.com

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target Raised to $30 00 at JPMorgan Chase & Co

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target Raised to $30 00 at JPMorgan Chase & Co
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Michaelr megnaSanjk patelVictory capital management incSg americas securitiesHedge funds weigh in on kiniksa pharmaceuticalsNews ratings for kiniksa pharmaceuticals dailyKiniksa pharmaceuticals company profileInsider activity at kiniksa pharmaceuticalsCapital management incJpmorgan chase coKiniksa pharmaceuticalsDynamic technology lab private ltdKiniksa pharmaceuticals tradingKiniksa pharmaceuticals ltdChina universal asset management coFree report

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Reaches New 1-Year High at $20 94

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Reaches New 1-Year High at $20 94
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Johnf paoliniMark ragosaSecurities exchange commissionYork mellon corpKiniksa pharmaceuticalsNews ratings for kiniksa pharmaceuticals dailyCharles schwab investment management incTejara capital ltdKiniksa pharmaceuticals ltdInsider activity at kiniksa pharmaceuticalsGroup plcKiniksa pharmaceuticals price performanceGet free reportExchange commissionNew york mellon corpGeneral group plc